Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.

[1]  O. Melander,et al.  Atrial fibrillation in the Malmö diet and cancer study: a study of occurrence, risk factors and diagnostic validity , 2010, European Journal of Epidemiology.

[2]  M. Pencina,et al.  Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. , 2009, JAMA.

[3]  F. Harrell,et al.  Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.

[4]  R. Vasan,et al.  Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study. , 2009, Archives of internal medicine.

[5]  D. Levy,et al.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study , 2009, The Lancet.

[6]  S. Connolly,et al.  Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.

[7]  Tamara B Harris,et al.  Incident Heart Failure Prediction in the Elderly: The Health ABC Heart Failure Score , 2008, Circulation. Heart failure.

[8]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[9]  N. Cook.  Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.

[10]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[11]  R. Rodeheffer,et al.  Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. , 2006, Journal of the American College of Cardiology.

[12]  Dirk Westermann,et al.  The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. , 2005, European heart journal.

[13]  E. Ingelsson,et al.  The validity of a diagnosis of heart failure in a hospital discharge register , 2005, European journal of heart failure.

[14]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[15]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[16]  B. Yawn,et al.  Trends in heart failure incidence and survival in a community-based population. , 2004, JAMA.

[17]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[18]  P. Shekelle,et al.  Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. , 2004, Journal of the American College of Cardiology.

[19]  Daniel Levy,et al.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death. , 2004, The New England journal of medicine.

[20]  Bruce M Psaty,et al.  Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.

[21]  D. Levy,et al.  Natural History of Asymptomatic Left Ventricular Systolic Dysfunction in the Community , 2003, Circulation.

[22]  P. Wilson,et al.  34th Bethesda Conference: Task force #4--How do we select patients for atherosclerosis imaging? , 2003, Journal of the American College of Cardiology.

[23]  Daniel Levy,et al.  The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening , 2003, Annals of Internal Medicine.

[24]  S. Yusuf,et al.  Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study , 2003, The Lancet.

[25]  W. Maisel,et al.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. , 2003, The American journal of cardiology.

[26]  J. Murabito,et al.  Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.

[27]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[28]  M Rosén,et al.  A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. , 2001, International journal of epidemiology.

[29]  J. Gardin,et al.  Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. , 2000, Journal of the American College of Cardiology.

[30]  D. Levy,et al.  Profile for estimating risk of heart failure. , 1999, Archives of internal medicine.

[31]  E. Braunwald.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[32]  L H Kuller,et al.  Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.

[33]  D. Levy,et al.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.

[34]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[35]  G. Novo,et al.  Biomarkers in heart failure. , 2009, Frontiers in bioscience.

[36]  N. Beauchamp,et al.  Task Force #4 —How Do We Select Patients for Atherosclerosis Imaging? , 2003 .

[37]  Ørnulf Borgan,et al.  A method for checking regression models in survival analysis based on the risk score , 1996, Lifetime data analysis.

[38]  Thomas J. Wang,et al.  Prediction of Heart Failure and Atrial Fibrillation ssessment of Conventional Cardiovascular Risk Factors and Multiple Biomarkers or the Prediction of Incident Heart Failure and Atrial Fibrillation , 2022 .